Article info
PDFCommentary
Use of a preclinical model of pancreas cancer to identify potential candidates for rapalogue therapy
- Correspondence to Dr Howard Crawford, Department of Cancer Biology, Mayo Clinic Florida, 4500 San Pablo Road, Jacksonville, FL 32224, USA; crawford.howard{at}mayo.edu
Citation
Use of a preclinical model of pancreas cancer to identify potential candidates for rapalogue therapy
Publication history
- Received June 2, 2014
- Accepted June 3, 2014
- First published June 25, 2014.
Online issue publication
August 03, 2014
Article Versions
- Previous version (25 June 2014).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions